Skip to content

News

Distributed Inventory Solution

    Since Mar, due to Omicron in China, all deliveries to China patients were significantly impacted, it’s the worst situation ever met in the past 3 COVID-19 years. To serve our customers better, we are going to build some stocks in China for emergencies. Any updates will keep in tune.

    GDMedz Guidelines for Hepatitis C Treatment

      HCV is a popular disease, and about millions of infected patients in Asia. According to GDMedz (former GDMeds), https://gdmedz.com/. Sale data, lots of them are located in China, India, and xxx… Today’s direct-acting antiviral (DAA) treatments (https://gdmedz.com/?s=sofosbuvir&post_type=product)  for hepatitis C are highly effective. The standard course of eight or 12 weeks of a daily medication… Read More »GDMedz Guidelines for Hepatitis C Treatment

      The Phoenix of HIV treatment

        Heads up from GDMeds pharmacy, The Asia and Pacific region was home to an estimated 5.8 million people living with HIV in 2019.1 China, India and Indonesia account for almost three-quarters of the total number of people living with HIV in the region.2   It is increasingly clear that the Asia and Pacific region is… Read More »The Phoenix of HIV treatment

        GDMedz Look Deep: COVID-19 vaccines – Effectiveness and Safety Details

          As a pharmacy and the distributor of anti-COVID-19 medicines, e.g. Remdesivir, Alltera, etc. GDMeds works on the frontline, and wish could support most people get necessary medicines and overcome this pandemic. As the pandemic rages on, it’s increasingly clear that widespread vaccination is essential to help contain it. Physical distancing, universal face coverings, and frequent… Read More »GDMedz Look Deep: COVID-19 vaccines – Effectiveness and Safety Details

          HCV Drugs Promotion

            Free shipping for buying 3 boxes of anti-Hepatitis C Drugs. Place order first, postage will be updated after order is approved.

            HIV PrEP Referrals Lag for Black MSM, Trans Adults

              State health departments were most likely to refer heterosexual adults for HIV preexposure prophylaxis (PrEP) appointments and least likely to refer transgender and Black adults, according to the results of a 12-city PrEP demonstration project. The project, Project PrIDE, was meant to close the PrEP gap between White and cisgender adults and their Black, Latinx, Native American, and transgender… Read More »HIV PrEP Referrals Lag for Black MSM, Trans Adults